DE3250068C2 - - Google Patents

Info

Publication number
DE3250068C2
DE3250068C2 DE3250068A DE3250068A DE3250068C2 DE 3250068 C2 DE3250068 C2 DE 3250068C2 DE 3250068 A DE3250068 A DE 3250068A DE 3250068 A DE3250068 A DE 3250068A DE 3250068 C2 DE3250068 C2 DE 3250068C2
Authority
DE
Germany
Prior art keywords
globulin
treated
fragment
human
vol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3250068A
Other languages
German (de)
English (en)
Inventor
Tetsuzo Urawa Saitama Jp Sugisaki
Shinichi Tokio/Tokyo Jp Morisue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DAINIPPON PHARMACEUTICAL Co Ltd OSAKA JP
Original Assignee
DAINIPPON PHARMACEUTICAL Co Ltd OSAKA JP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DAINIPPON PHARMACEUTICAL Co Ltd OSAKA JP filed Critical DAINIPPON PHARMACEUTICAL Co Ltd OSAKA JP
Application granted granted Critical
Publication of DE3250068C2 publication Critical patent/DE3250068C2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE3250068A 1981-07-28 1982-07-27 Expired - Fee Related DE3250068C2 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56118928A JPS5821623A (ja) 1981-07-28 1981-07-28 抗原抗体複合体沈着疾患治療剤

Publications (1)

Publication Number Publication Date
DE3250068C2 true DE3250068C2 (it) 1992-08-06

Family

ID=14748668

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19823228007 Granted DE3228007A1 (de) 1981-07-28 1982-07-27 Arzneimittel zur behandlung von systemischem lupus erythematodes und primaerer glomerulonephritis
DE3250068A Expired - Fee Related DE3250068C2 (it) 1981-07-28 1982-07-27

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19823228007 Granted DE3228007A1 (de) 1981-07-28 1982-07-27 Arzneimittel zur behandlung von systemischem lupus erythematodes und primaerer glomerulonephritis

Country Status (3)

Country Link
JP (1) JPS5821623A (it)
DE (2) DE3228007A1 (it)
IT (1) IT1156482B (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59101427A (ja) * 1982-11-30 1984-06-12 Teijin Ltd 腎疾患治療剤
JPS59190922A (ja) * 1983-04-12 1984-10-29 Green Cross Corp:The 炎症治療予防剤
FR2556219B1 (fr) * 1983-12-07 1987-06-26 Merieux Inst Nouveau medicament immunomodulateur, a base de fragments fc d'igg humaines
JPH0643343B2 (ja) * 1984-12-28 1994-06-08 株式会社ミドリ十字 免疫調節剤

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3763135A (en) * 1971-11-08 1973-10-02 Baxter Laboratories Inc Gamma globulin production from cohn fraction iii using polyethylene glycol
US4059571A (en) * 1974-03-08 1977-11-22 Teijin Limited Novel immunoglobulin derivatives and process for the preparation thereof
US4093606A (en) * 1975-02-18 1978-06-06 Coval M L Method of producing intravenously injectable gamma globulin and a gamma globulin suitable for carrying out the method
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
US4165370A (en) * 1976-05-21 1979-08-21 Coval M L Injectable gamma globulin

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3763135A (en) * 1971-11-08 1973-10-02 Baxter Laboratories Inc Gamma globulin production from cohn fraction iii using polyethylene glycol
US4059571A (en) * 1974-03-08 1977-11-22 Teijin Limited Novel immunoglobulin derivatives and process for the preparation thereof
US4093606A (en) * 1975-02-18 1978-06-06 Coval M L Method of producing intravenously injectable gamma globulin and a gamma globulin suitable for carrying out the method
US4165370A (en) * 1976-05-21 1979-08-21 Coval M L Injectable gamma globulin
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
A. Polson, C. Ruiz-Bravo: Vox Sang 23 (1972), S. 107-118 *
C.L. Anderson u. W.S. Stillmann: J. Clin. Invest. 66 (1980), S. 353-360 *
D.R. Budman et al.: Arthritis and Rheumatism 20 (1977), S. 829-833 *
F. Skvaril, I. Gozze: Int. Archs Allergy appl. Immun. 57 (1978), S. 375-378 *
H. Sano, C. Morimoto: The Journal of Immunology 126 (1981), S. 538-539 *
J.T. Sgouris: Vox Sang 13 (1967), S. 71-85 *
W. Stephan: Vox Sang 20 (1971), S. 442-457 *
W. Stephan: Vox Sang 28 (1975), S. 422-437 *
Y. Masuho et al.: Vox Sang 32 (1977), S. 175-181 *
Y. Masuho et al.: Vox Sang 32 (1977), S. 290-295 *

Also Published As

Publication number Publication date
JPH0250884B2 (it) 1990-11-05
IT8267956A0 (it) 1982-07-28
DE3228007C2 (it) 1992-01-30
JPS5821623A (ja) 1983-02-08
DE3228007A1 (de) 1983-02-17
IT1156482B (it) 1987-02-04

Similar Documents

Publication Publication Date Title
DE69130289T2 (de) Therapeutische verwendung von actin-bindenden verbindungen
Katzman Electrolyte distribution in mammalian central nervous system: Are glia high sodium cells?
DE69633717T2 (de) Monoklonale anti-cd6 antikörper zur behandlung und diagnose von psoriasis
DE2804457C2 (de) Immunsuppressive Mittel
DE2936047C2 (it)
DE69425246T2 (de) Monoklonale antikoerper gegen lfa-1 zur herstellung eines arzneimittels zur vorbeugung der transplantatabstossung von organen
DE69632476T2 (de) Behandlung von dilatierte kardiomyopathie durch entfernung von autoantikoerpern
DE69424362T2 (de) Verwendung von Histamin-gamma-globulin zur Herstellung eines immunomodulierenden und antiinflammatorischen Agens
DE69535593T2 (de) Verwendung von hgf zur herstellung eines arzneimittels zur behandlung von lungenfibrose
DE112013001457T5 (de) Transdermales Applikationssystem
CH642852A5 (de) Material, das zur markierung mit einem radionuklid geeignet ist, verfahren zu dessen herstellung und dessen verwendung.
DE112011102396T5 (de) Pharmazeutische Kombinationszusammensetzung und Verfahren zur Behandlung von Diabetes und metabolischen Störungen
DE112011102356T5 (de) Pharmazeutische Kombinationszusammensetzung und Verfahren zur Behandlung von Erkrankungen oder Zuständen, die mit dem Herz-Kreislauf-System in Verbindung stehen
DE2827027B2 (de) Gefriergetrocknetes natives T -globulin-Präparat zur intravenösen Verabreichung
DE3390419T1 (de) Arzneimittel zur Behandlung der Ulkuskrankheit
DE19737348A1 (de) Neue pharmazeutische Zusammensetzung
DE3026180A1 (de) Verwendung von rifamycin sv und seinen salzen in form von praeparaten zur intraartikulaeren injektion bei der bekaempfung von rheumatoider arthritis
DE194851T1 (de) Therapie der menschlichen tumore.
DE3250068C2 (it)
DE69303305T2 (de) Mittel zur Behandlung chronischer Ermüdungserscheinungen
DE2206570B2 (de) Verwendung von ( + ) - Catechin
DE3707127C2 (de) Verwendung von Methionin zur Behandlung von Immun-Schwächeerkrankungen bei Virusinfektionen und/oder bei Tumorerkrankungen
DE3781045T2 (de) Antirheumatisches arzneimittel.
DE69227918T2 (de) VERWENDUNG EINES CDw52-SPEZIFISCHEN ANTIKÖRPERS ZUR BEHANDLUNG VON DURCH T-ZELLEN VERMITTELTEN GELENKENTZÜNDUNGEN
AT408719B (de) Mittel zur behandlung von hepatitis c

Legal Events

Date Code Title Description
Q172 Divided out of (supplement):

Ref country code: DE

Ref document number: 3228007

8110 Request for examination paragraph 44
AC Divided out of

Ref country code: DE

Ref document number: 3228007

Format of ref document f/p: P

AC Divided out of

Ref country code: DE

Ref document number: 3228007

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Free format text: TAUCHNER, P., DIPL.-CHEM. DR.RER.NAT. HEUNEMANN, D., DIPL.-PHYS. DR.RER.NAT. RAUH, P., DIPL.-CHEM. DR.RER.NAT. HERMANN, G., DIPL.-PHYS. DR.RER.NAT. SCHMIDT, J., DIPL.-ING. JAENICHEN, H., DIPL.-BIOL. DR.RER.NAT., PAT.-ANWAELTE TREMMEL, H., RECHTSANW., 8000 MUENCHEN

8339 Ceased/non-payment of the annual fee